Assoc Prof Takeuchi Hiroyoshi

Plenary Speaker

After graduating from Chiba University School of Medicine in 2001, Dr Takeuchi joined Keio University School of Medicine as a clinician-researcher.

After completing his PhD programme at Keio University School of Medicine in 2012, Dr Takeuchi worked as a postdoctoral/clinical fellow at Centre for Addiction and Mental Health in Toronto until 2017. His primary research interest is optimising antipsychotic treatment for schizophrenia across the illness stage (i.e., first-episode to treatment-resistant schizophrenia) and the treatment phase (i.e., acute to maintenance treatment) to improve cognitive impairment and negative symptoms, core but treatment resistant features in schizophrenia, while minimising side effects.